Speaker Details

Ameet Mallik
Global Head of Sandoz Biopharmaceuticals & Oncology Injectables, Sandoz

Ameet Mallik joined Sandoz as Global Head of Biopharmaceuticals in August 2009. In May 2011, he was appointed to an expanded role as Global Head of Biopharmaceuticals & Oncology Injectables.

Previously, Ameet was Brand Director for Tekturna for Novartis Pharma in the US. He joined Novartis Pharma in 2005 as Head of Global Strategic Planning and was a member of the Pharma Executive Committee.

Before joining Novartis, Ameet spent five years at McKinsey & Company in the US. He started his career at Abbott Labs in the US, holding roles in engineering and business development.

A US national, Ameet graduated with a BSc in Chemical Engineering and an MSc in Biotechnology from Northwestern University, US. He holds an MBA from the Wharton School at the University of Pennsylvania, US.